[ad_1] COPENHAGEN, Oct 5 (Reuters) – The whirlwind success of weight-loss treatment Wegovy is providing a bonanza not just for its developer, Novo Nordisk (NOVOb.CO), but also for its home…
[ad_1] COPENHAGEN, Oct 5 (Reuters) – The whirlwind success of weight-loss treatment Wegovy is providing a bonanza not just for its developer, Novo Nordisk (NOVOb.CO), but also for its home…